Iberogast Neo

Iberogast Neo, the active ingredient in Iberogast Neo, is a herbal botanical presented as an oral liquid for oral use. It is used to support digestive comfort in adults and children with functional gastrointestinal symptoms.

GNH USA supplies Iberogast Neo as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Iberogast Neo is used to address functional gastrointestinal disorders.

- Functional dyspepsia: helps relieve upper abdominal discomfort, early satiety and fullness. - Irritable bowel syndrome (IBS): may reduce abdominal pain, cramping and irregular bowel habits. - Functional bloating: assists in decreasing abdominal distension and excess gas.

Iberogast Neo is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Altered taste sensation: mild metallic or bitter aftertaste. - Nausea: transient feeling of queasiness. - Flatulence: increased intestinal gas. - Diarrhoea: loose stools. - Abdominal discomfort: mild cramping. - Headache: occasional mild headache.

Serious or Rare Side Effects: - Allergic reaction: rash, itching or swelling. - Angioedema: rapid swelling of face, lips or tongue. - Severe skin eruption: Stevens‑Johnson‑like rash. - Liver enzyme elevation: abnormal hepatic function tests. - Anaphylaxis: life‑threatening systemic allergic response.

Before using Iberogast Neo, consider the following safety measures.

- Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a physician. - Concomitant medications: inform the prescriber of all current drugs. - Underlying liver disease: use with caution and monitor liver function. - Age restrictions: not recommended for children under 12 years unless advised by a clinician. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Iberogast Neo may interact with certain medicines; review the following categories.

Major Interactions (Avoid): - Anticholinergic agents: may amplify antispasmodic effects leading to excessive gut motility reduction. - Strong CYP450 inhibitors: could increase exposure to herbal constituents. - Warfarin: potential enhancement of anticoagulant activity.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: altered gastric pH may affect herbal absorption. - Selective serotonin reuptake inhibitors (SSRIs): monitor for changes in gastrointestinal symptoms.